| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.04▼ | 1.04▼ | 1.04▼ | 1.08▼ | 1.13▼ |
| MA10 | 1.04▼ | 1.05▼ | 1.06▼ | 1.05▼ | 1.21▼ |
| MA20 | 1.05▼ | 1.07▼ | 1.09▼ | 1.11▼ | 1.13▼ |
| MA50 | 1.08▼ | 1.06▼ | 1.04▼ | 1.22▼ | 0.85▲ |
| MA100 | 1.06▼ | 1.06▼ | 1.11▼ | 1.13▼ | 0.97▲ |
| MA200 | 1.05▼ | 1.12▼ | 1.17▼ | 0.86▲ | 1.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.000▼ | -0.006▼ | -0.009▼ | 0.000▲ | -0.024▼ |
| RSI | 37.756▼ | 38.524▼ | 39.297▼ | 41.088▼ | 50.332▲ |
| STOCH | 27.778 | 6.410▼ | 12.527▼ | 53.952 | 35.457 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -70.000 | -68.155 |
| CCI | -185.260▼ | -95.165 | -126.008▼ | -36.089 | -65.219 |
| MA | $ONCY Price Crossed Below MA(7) | Set Alert |
|
Tuesday, November 04, 2025 05:38 AM
Oncolytics Biotech® Establishes Gastrointestinal Tumor Scientific Advisory Board to Advance Pelareorep as a Platform Immunotherapy ...
|
|
Tuesday, October 28, 2025 06:16 PM
The MarketWatch News Department was not involved in the creation of this content. Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (>=2L) squamous cell anal carcinoma (SCAC) ...
|
|
Tuesday, October 28, 2025 05:30 AM
SAN DIEGO, Calif., Oct. 28, 2025 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today announced ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 1.07 | 1.11 | 1.025 | 1.04 | 850,346 |
| 13/11/25 | 1.11 | 1.13 | 1.08 | 1.08 | 461,581 |
| 12/11/25 | 1.09 | 1.15 | 1.08 | 1.135 | 441,275 |
| 11/11/25 | 1.06 | 1.09 | 1.0244 | 1.08 | 383,628 |
| 10/11/25 | 1.01 | 1.09 | 1.01 | 1.07 | 649,144 |
| 07/11/25 | 1.00 | 1.04 | 0.97 | 1.02 | 503,250 |
| 06/11/25 | 0.99 | 1.05 | 0.9818 | 1.01 | 726,129 |
| 05/11/25 | 0.9504 | 1.03 | 0.9501 | 1.01 | 821,943 |
| 04/11/25 | 1.11 | 1.1258 | 0.92 | 0.9649 | 2,968,509 |
| 03/11/25 | 1.18 | 1.19 | 1.08 | 1.09 | 1,269,461 |
|
|
||||
|
|
||||
|
|